Zura Bio Limited
ZURA
$1.21
-$0.05-3.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -125.15% | -60.80% | -150.33% | 69.64% | 19.23% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.59% | 99.93% | 408.79% | -87.79% | -50.89% |
| Change in Net Operating Assets | 1,290.31% | -100.83% | -21.63% | 101.38% | -193.80% |
| Cash from Operations | -122.06% | -167.06% | -119.88% | -27.91% | -52.96% |
| Capital Expenditure | -600.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | 100.00% | -- |
| Cash from Investing | 99.02% | -- | 99.42% | 99.83% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -2.38% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 92.93% | 170.80% | -- |
| Cash from Financing | -- | -- | 232.07% | 31.96% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 40.64% | -189.24% | 97.52% | 43.27% | -123.56% |